Vertex Pharmaceuticals Incorporated shares owned by Bank Of Oklahoma National Association /
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bank Of Oklahoma National Association /
from 13F filings
Historical chart of Bank Of Oklahoma National Association / investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Bank Of Oklahoma National Association / consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bank Of Oklahoma National Association /
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.9M | 20k | 406.89 |
| 2023-09-30 | $7.1M | 20k | 362.11 |
| 2023-06-30 | $6.8M | 19k | 351.91 |
| 2023-03-31 | $6.3M | 20k | 315.07 |
| 2022-12-31 | $6.7M | 23k | 288.78 |
| 2022-09-30 | $2.0M | 6.8k | 289.26 |
| 2022-06-30 | $1.9M | 6.9k | 281.56 |
| 2022-03-31 | $3.0M | 12k | 260.99 |
| 2021-12-31 | $2.5M | 12k | 219.83 |
| 2021-09-30 | $2.4M | 13k | 181.25 |
| 2021-03-31 | $3.6M | 17k | 214.66 |
| 2020-12-31 | $9.9M | 42k | 236.30 |
| 2020-09-30 | $12M | 44k | 272.17 |
| 2020-06-30 | $14M | 49k | 290.35 |
| 2020-03-31 | $12M | 49k | 237.97 |
| 2019-12-31 | $9.6M | 44k | 218.88 |
| 2019-09-30 | $5.2M | 31k | 169.27 |
| 2019-06-30 | $8.0M | 44k | 183.37 |
| 2019-03-31 | $7.2M | 39k | 183.85 |
| 2018-12-31 | $5.7M | 35k | 165.59 |
| 2018-09-30 | $2.7M | 14k | 192.66 |
| 2018-06-30 | $1.1M | 6.4k | 170.34 |
| 2018-03-31 | $618k | 3.8k | 162.52 |
| 2017-12-31 | $274k | 1.9k | 147.37 |
| 2017-09-30 | $321k | 2.2k | 144.93 |
| 2017-06-30 | $322k | 2.5k | 130.43 |
| 2013-09-30 | $158k | 2.7k | 58.82 |
| 2013-06-30 | $171k | 2.6k | 66.67 |
More positions owned by Bank Of Oklahoma National Association /
View all positions for Bank Of Oklahoma National Association /
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated